CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | Stock-Healthcare | 45.29% | -21.90% | — | |
| 2 | RUBYUSD | Rubius Therapeutics INC | Stock-Other | 26.23% | — | — | |
| 3 | KLDO | Kaleido Biosciences INC | Stock-Other | 9.53% | — | — | |
| 4 | DNLI | Denali Therapeutics INC | Stock-Other | 7.04% | — | -10.24% | |
| 5 | ✓ | Evelo Biosciences INC | Stock-Other | 5.52% | — | — | |
| 6 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 3.30% | — | — | |
| 7 | QTRX | Quanterix CORP | Stock-Other | 1.98% | — | — | |
| 8 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 1.11% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | +1.4% | — | Unchanged |
| 2 | MCRB1EUR | Seres Therapeutics INC | +0.5% | — | Unchanged |
| 3 | SYRSEUR | Syros Pharmaceuticals INC | +0.2% | — | Unchanged |
| 4 | QTRX | Quanterix CORP | +0.2% | — | Unchanged |
| 5 | DNLI | Denali Therapeutics INC | -2% | -10.24% | Trim |
| 6 | RUBYUSD | Rubius Therapeutics INC | -3.8% | — | Unchanged |
| 7 | ✓ | Evelo Biosciences INC | -6.1% | — | Unchanged |
| 8 | KLDO | Kaleido Biosciences INC | — | NEW | New buy |